Company intelligence / Profile preview
Shining Biotechnology
Shanghai, Shanghai, Chinashining-biotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shining Biotechnology specializes in innovative cell therapies and cancer vaccines aimed at extending patient survival, reducing treatment pain, improving quality of life, and providing better options for critically ill patients. It collaborates closely with Japan’s leading immuno-oncology institute to advance next-generation immune therapies. No published clinical results or approved products were found as of the latest update.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyVaccine
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
The Institute of Medical Oncology (TIMO), Japan
Beyond the preview
Go deeper on Shining Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shining Biotechnology.